| A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence (NCT00768482) | Titan Pharmaceuticals | 2008-09-01 |
| Drug Discrimination in Methadone-Maintained Humans Study 2 (NCT00733239) | University of Arkansas | 2008-08-01 |
| Methadone Maintenance & HIV Risk in Ukraine (NCT00351026) | University of Pennsylvania | 2008-06-01 |
| The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment (NCT00857350) | Yale University | 2008-06-01 |
| Relapse Prevention to Reduce HIV Among Women Prisoners (NCT00763958) | University of Alabama at Birmingham | 2008-05-01 |
| Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence (NCT00630201) | Titan Pharmaceuticals | 2007-10-01 |
| Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients (NCT00420771) | New York State Psychiatric Institute | 2007-01-01 |
| Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-maintained Patients. (NCT00593125) | Yale University | 2007-01-01 |
| Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users (NCT01741350) | University of Connecticut | 2006-09-01 |
| Integrating Buprenorphine Into the SFGH AIDS Program (NCT00263458) | University of California, San Francisco | 2005-12-01 |
| Depot Naltrexone Treatment of Opioid Dependent Parolees (NCT00756990) | University of Pennsylvania | 2005-11-01 |
| FMRI of Stress and Addictive Disorders (NCT01558973) | Yale University | 2005-08-01 |
| RCT Comparing Methadone and Buprenorphine in Pregnant Women (NCT00271219) | Johns Hopkins University | 2005-07-01 |
| Memantine and Naltrexone Treatment for Opioid Dependence (NCT00125515) | New York State Psychiatric Institute | 2005-06-01 |
| Pharmacogenetics of Disulfiram for Cocaine (NCT00149630) | Baylor College of Medicine | 2005-01-01 |
| The German Project of Heroin Assisted Treatment of Opiate Dependent Patients (NCT00268814) | Universitätsklinikum Hamburg-Eppendorf | 2002-03-01 |
| Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14 (NCT00015340) | National Institute on Drug Abuse (NIDA) | 1999-08-01 |
| Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse (NCT00292123) | National Institute on Drug Abuse (NIDA) | 1999-06-01 |
| Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2 (NCT00249457) | Johns Hopkins University | 1996-10-01 |
| Opioid Maintenance Medications Comparison Study (NCT00344812) | Johns Hopkins University | 1996-01-01 |
| The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects (NCT02516436) | BioDelivery Sciences International | |
| Evaluation of BEMA® Buprenorphine NX for Buprenorphine Induction of Opioid Dependent Subjects (NCT01713803) | BioDelivery Sciences International | |